HEMATOLOGY

Endocrine Cancer Predisposition Syndromes: Hereditary Paraganglioma, Multiple Endocrine Neoplasia Type 1, Multiple Endocrine Neoplasia Type 2, and Hereditary Thyroid Cancer

Sep 18, 2017 by in HEMATOLOGY Comments Off on Endocrine Cancer Predisposition Syndromes: Hereditary Paraganglioma, Multiple Endocrine Neoplasia Type 1, Multiple Endocrine Neoplasia Type 2, and Hereditary Thyroid Cancer

The hereditary paraganglioma, MEN1, MEN2, and hereditary thyroid cancer syndromes are clinically discernable and genetically distinct. The first 3 syndromes have been well characterized in the past 10 to 15…

read more

Genitourinary Cancer Predisposition Syndromes

Sep 18, 2017 by in HEMATOLOGY Comments Off on Genitourinary Cancer Predisposition Syndromes

Despite epidemiologic data supporting a significant genetic contribution to the cause of genitourinary malignancies, their diagnosis rarely results in clinical genetics referral and the heritability of prostate, bladder, kidney, and…

read more

Hereditary Genodermatoses with Cancer Predisposition

Sep 18, 2017 by in HEMATOLOGY Comments Off on Hereditary Genodermatoses with Cancer Predisposition

In this article hereditary genodermatoses with cancer predisposition are reviewed, including nevoid basal cell carcinoma syndrome, neurofibromatosis types 1 and 2, tuberous sclerosis complex, xeroderma pigmentosum, and dyskeratosis congenita. Hereditary…

read more

Clinical Genetics of Hereditary Colorectal Cancer

Sep 18, 2017 by in HEMATOLOGY Comments Off on Clinical Genetics of Hereditary Colorectal Cancer

Colorectal cancer (CRC) is a common disease, and approximately 25% of patients have a familial component. High-penetrance singlegene germline mutations conferring a true hereditary susceptibility account for around 5% to…

read more

Upper Gastrointestinal Cancer Predisposition Syndromes

Sep 18, 2017 by in HEMATOLOGY Comments Off on Upper Gastrointestinal Cancer Predisposition Syndromes

Malignancies of the upper gastrointestinal tract form a heterogeneous group of cancers characterized by unique epidemiology and biology. Despite these differences, survival for advanced disease remains poor across the panel…

read more
Get Clinical Tree app for offline access